Using a patient prompt list to raise concerns in oncology clinics does not necessarily lead to longer consultations

Head and neck oncology post-treatment consultations form a critical component of care in terms of support and surveillance. They occur frequently in the first few years and can place substantial demands on healthcare resources. However, they provide useful opportunities for patients to raise issues...

Full description

Saved in:
Bibliographic Details
Published in:British journal of oral & maxillofacial surgery 2020-11, Vol.58 (9), p.1164-1171
Main Authors: Rogers, S.N., Semple, C., Humphris, G.M., Lowe, D., Kanatas, A.
Format: Article
Language:English
Subjects:
Communication
consultations
duration
head and neck cancer
Head and Neck Neoplasms - therapy
health-related quality of life
Humans
intervention
Patient Concerns Inventory
Percutaneous Coronary Intervention
Physician-Patient Relations
prompt list
Quality of Life
randomised trial
Referral and Consultation
Surveys and Questionnaires
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Head and neck oncology post-treatment consultations form a critical component of care in terms of support and surveillance. They occur frequently in the first few years and can place substantial demands on healthcare resources. However, they provide useful opportunities for patients to raise issues and receive tailored information and support. The aim of this paper was to assess whether completion of a 56-item patient prompt list (PCI - the Patient Concerns Inventory) immediately prior to the consultation significantly increased its duration. This was a pragmatic cluster preference randomised controlled trial of 288 patients with 15 consultant clusters from two sites “using” (n=8) or “not using” (n=7) the PCI. Consultation times were known for 283 patients (136 PCI, 147 non-PCI) who attended their first post-treatment trial consultation a median (IQR) of 103 (70-160) days after the end of treatment. Consultations lasted a median (IQR) of 10 (7-13) minutes (mean 11) in non-PCI patients and a median (IQR) of 11 (8-15) minutes (mean 12) in PCI patients (p=0.07). After adjustment for patient clustering and significant case mix, the 95% confidence interval for the mean difference was between 1.45minutes shorter with the PCI and 2.98minutes longer (p=0.50). There was significant variation in duration by consultant, tumour stage, treatment mode, overall quality of life (QoL), and distress (all p
ISSN:0266-4356
1532-1940
DOI:10.1016/j.bjoms.2020.08.035